In the News
The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.
Published: July 09, 2020
Scientist are ready to trial a new cancer vaccine in humans following the successful outcome of their preclinical studies. The new vaccine was developed by a Master Research team based at Translational Resea ... More >>.
Published: July 01, 2020
Seeking to ignite the next major breakthrough to treat blood cancers, The Leukemia & Lymphoma Society (LLS), The Mark Foundation, and The Paul G. Allen Frontiers Group today announced more than $6.75 mil ... More >>.
Published: May 08, 2020
A team of scientists and physicians from the University of Zurich (UZH), the University Hospital Zurich (USZ) and ETH Zurich have now managed to eliminate the leukemic and hematopoietic stem cells more selec ... More >>.
Published: May 01, 2020
As part of The LLS Children's Initiative, LLS is working with a team of renowned pediatric oncologists to lay the groundwork for a global precision medicine master clinical trial to match children with relap ... More >>.
Published: March 31, 2020
Author: Roxanne Nelson, RN, BSN
Chronic lymphocytic leukemia (CLL) is the most common form of leukemia diagnosed in adults residing in Western countries, and is a monoclonal disorder that is characterized by progressive accumulation of fun ... More >>.
Published: March 30, 2020
In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international ... More >>.
Published: March 10, 2020
Author: Christina Bennett, MS
Although anti-CD19 chimeric antigen receptor (CAR-T) therapy has led to dramatic results in patients with hematological malignancies who seemingly out of treatment options, it is far from a panacea for all p ... More >>.
Published: March 02, 2020
Dengue virus infection is associated with an increased risk of leukemia, according to a study published online Feb.12 in Cancer Epidemiology, Biomarkers & Prevention.
Yu-Wen Chien, Ph.D. ... More >>.
Published: January 17, 2020
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia (AML), one of the most common forms of blood cancer. This is the conclusion of a study in ... More >>.
Published: December 06, 2019
The Leukemia & Lymphoma Society (LLS) and the American Society of Hematology (ASH) announced today a collaboration to expand access to LLS's unique free service providing clinical trials navigation and s ... More >>.